Nemus Bioscience Inc. (OTCQB: NMUS) received a $1.75 million private placement from majority shareholder Emerald Health Sciences Inc. and other investors.
UCI to Fill Two Positions; Providence Taps New Head
High performers like UC Irvine Medical Center and Providence St. Joseph Health—its local network comprised of seven hospitals—experienced changes on the executive level in the year ended Sept. 30, the former in search of a new chief executive, the latter naming a regional head to oversee Los Angeles, Orange and San Bernardino counties.
If there’s one word to describe the nation’s healthcare industry it’s uncertainty. The new tax bill repealed the Affordable Care Act’s individual mandate provisions that required most Americans to purchase health insurance or face penalty, which could hurt hospital revenue with fewer people buying health plans. The bill also took away nonprofit hospitals’ ability to use advanced refunding to replace outstanding bonds with bonds at lower interest rates.
Include Monitoring, More Access to Care on Demand
Digital health is the buzzword when it comes to the present and the future of care. Technologies, such as telemedicine, remote patient monitoring and patient engagement via smartphones, are designed to enable providers and patients to manage health and wellness more effectively and cost-efficiently.
Hospitals Up Game To Better Coordinate Care
It was the worst of times and the worst timing. “The uptick in flu cases in mid-December spiked around Christmas and New Year’s Eve, around the holidays, a lot of traveling and socializing with family and friends,” said Dr. Wendy Coling, a Kaiser Permanente primary care physician in Orange County. She said it didn’t help that this year’s H3N2 influenza virus is a “more virulent flu strain.”
Tustin-based Avid Bioservices Inc. yesterday priced a public offering of 9 million shares of common stock at $2.25 apiece, and expects more than $20 million in gross proceeds after the offering closes next week.
Avid Bioservices Inc. in Tustin will sell its clinical-stage immunotherapy cancer drug candidate to Oncologie Inc. for $8 million upfront—with payments spread over six months—and up to $95 million in development, regulatory and commercialization milestones.
HEALTHCARE: New Aliso Viejo HQ; hiring 120
A primary care doctor is the first stop for a patient’s medical care, including chronic disease management.
Got European, US Clearances, Stock Uptick
January was a busy month for Irvine-based patient monitoring device maker Masimo Corp., which announced Food and Drug Administration approval of two devices.
Lake Forest-based ReVision Optics Inc. has shut down saying, “it is with regret, that we have to close our doors.”